Literature DB >> 15262853

Vulnerable plaque: the devil is in the details.

Zorina S Galis.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15262853     DOI: 10.1161/01.CIR.0000135195.60131.59

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  Electrochemical impedance spectroscopy to assess vascular oxidative stress.

Authors:  Fei Yu; Rongsong Li; Lisong Ai; Collin Edington; Hongyu Yu; Mark Barr; E S Kim; Tzung K Hsiai
Journal:  Ann Biomed Eng       Date:  2010-07-23       Impact factor: 3.934

2.  High glucose and Nepsilon-(carboxymethyl) lysine bovine serum albumin modulate release of matrix metalloproteinases in cultured human endothelial cells.

Authors:  Sedegheh Gharagozlian; Tore Henriksen; Svein Olav Kolset
Journal:  Eur J Nutr       Date:  2006-05-16       Impact factor: 5.614

Review 3.  Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview.

Authors:  L M Riou; A Broisat; J Dimastromatteo; G Pons; D Fagret; C Ghezzi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

4.  Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo.

Authors:  Vardan Amirbekian; Juan Gilberto S Aguinaldo; Smbat Amirbekian; Fabien Hyafil; Esad Vucic; Marc Sirol; David B Weinreb; Soizic Le Greneur; Eric Lancelot; Claire Corot; Edward A Fisher; Zorina S Galis; Zahi A Fayad
Journal:  Radiology       Date:  2009-05       Impact factor: 11.105

5.  Characterization of coronary plaques with combined use of intravascular ultrasound, virtual histology and optical coherence tomography.

Authors:  Guillermo Sánchez-Elvira; Isabel Coma-Canella; Miguel Artaiz; José Antonio Páramo; Joaquín Barba; José Calabuig
Journal:  Heart Int       Date:  2010-12-31

6.  Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice.

Authors:  Pengfei Zuo; Zhi Zuo; Yueyue Zheng; Xin Wang; Qianxing Zhou; Long Chen; Genshan Ma
Journal:  Front Pharmacol       Date:  2017-09-14       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.